Form 4: Natera CFO Michael Brophy Reports Stock Transactions
SEC Form 4 Filing
Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- Michael Brophy, the CFO of Natera, Inc., filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve the vesting of restricted stock units (RSUs) and the subsequent sale of common stock to satisfy tax withholding obligations.
- On July 20, 2024, 1,522 RSUs vested, followed by 1,145 on July 21, 2024, and 1,250 on July 22, 2024.
- Shares were sold on July 22, 2024, at a weighted average price of $105.1596, and on July 23, 2024, at $107.3979.
- These sales were executed under a pre-arranged trading plan (Rule 10b5-1(c)).
- Following these transactions, Brophy directly owns 77,418 shares of common stock and 6,250 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations. There's no indication of unusual or concerning activity.
Positives
- The transactions are part of a pre-arranged trading plan (Rule 10b5-1(c)), suggesting they were planned in advance and not based on current market sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance.
Comparison to Industry Standards
- Comparing Natera's insider trading activity to companies like Exact Sciences (EXAS) or Guardant Health (GH) can provide context.
- Similar insider sales related to RSU vesting are common across the biotech industry.
- The use of Rule 10b5-1 trading plans is a standard practice to avoid accusations of insider trading.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
- The use of a Rule 10b5-1(c) trading plan ensures transparency and reduces the risk of insider trading concerns.
Key Dates
| Date | Description |
|---|---|
| 01/22/2021 | Date of Stock Unit Agreements granted to the Reporting Person |
| 01/28/2022 | Date of Stock Unit Agreements granted to the Reporting Person |
| 10/22/2021 | Date of Stock Unit Agreement granted to the Reporting Person |
| 01/20/2023 | 25% of RSUs vested |
| 07/20/2024 | 1,522 RSUs vested and converted to common stock |
| 07/21/2024 | 1,145 RSUs vested and converted to common stock |
| 07/22/2024 | 1,250 RSUs vested and converted to common stock; 1,059 shares sold at $105.1596 average price |
| 07/23/2024 | 499 shares sold at $107.3979 average price |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.